Why the study?
Prevalence and incidence of hepatitis caused by HEV infection are typically higher in developing countries, prompting evaluation of HEV seroprevalence and incidence in patients with clinical hepatitis at a tertiary hospital in Thailand.
What is the prevalence of HEV antibodies in patients suspected of HEV infection in a tertiary hospital in Thailand?
Population
1106 serum samples from patients suspected of HEV infection in Thailand
Comparison
Patients with different HEV serological statuses
Design
Laboratory-based cross-sectional study
Authors
Loading...
May prompt HEV testing in Thai hepatitis patients; leaves open need for incidence tracking and prevention trials.
What is the prevalence of HEV antibodies in patients suspected of HEV infection in a tertiary hospital in Thailand?
HEV seroprevalence is relatively high among patients with clinical hepatitis in Thailand, including vulnerable subgroups like pregnant women and organ transplant recipients.
Boonyai et al. (2021) studied this question.